Pre-cART (combined antiretroviral therapy) plasma viral load >500,000 copies/ml has been associated with a lower probability of achieving virological suppression, while few data about its role on maintenance of virological suppression are available. In this study we aimed to clarify whether high levels of pre-cART viraemia are associated with virological rebound (VR) after virological suppression.
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen / Armenia, Daniele; Di Carlo, Domenico; Cozzi-Lepri, Alessandro; Calcagno, Andrea; Borghi, Vanni; Gori, Caterina; Bertoli, Ada; Gennari, William; Bellagamba, Rita; Castagna, Antonella; Latini, Alessandra; Pinnetti, Carmela; Cicalini, Stefania; Saracino, Annalisa; Lapadula, Giuseppe; Rusconi, Stefano; Castelli, Francesco; Di Giambenedetto, Simona; Andreoni, Massimo; Di Perri, Giovanni; Antinori, Andrea; Mussini, Cristina; Ceccherini-Silberstein, Francesca; Monforte, Antonella D'Arminio; Perno, Carlo F; Santoro, Maria M. - In: ANTIVIRAL THERAPY. - ISSN 1359-6535. - 24:5(2019), pp. 321-331. [10.3851/IMP3309]
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen
Mussini, Cristina;
2019
Abstract
Pre-cART (combined antiretroviral therapy) plasma viral load >500,000 copies/ml has been associated with a lower probability of achieving virological suppression, while few data about its role on maintenance of virological suppression are available. In this study we aimed to clarify whether high levels of pre-cART viraemia are associated with virological rebound (VR) after virological suppression.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Cozzi-Lepri_AVT-18-OA-4455_Armenia_IP2.pdf
Open access
Tipologia:
Versione dell'autore revisionata e accettata per la pubblicazione
Dimensione
785.8 kB
Formato
Adobe PDF
|
785.8 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
